Publications by authors named "Viola Franke"

Claim this Profile
T
Talimogene laherparepvec monotherapy for head and neck melanoma patients.
Viola Franke, Emma H A Stahlie, Willem M C Klop, Charlotte L Zuur, Danique M S Berger

Melanoma Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.
Maartje W Rohaan, Emma H A Stahlie, Viola Franke, Lisanne P Zijlker, Sofie Wilgenhof

BMC Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-introduction of T-VEC Monotherapy in Recurrent Melanoma is Effective.
Viola Franke, Emma H A Stahlie, Bernies van der Hiel, Bart A van de Wiel, Michel W J M Wouters

J Immunother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model.
Emma H A Stahlie, Viola Franke, Charlotte L Zuur, Willem M C Klop, Bernies van der Hiel

Cancer Immunol Immunother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European Countries.
Alexander C J van Akkooi, Sebastian Haferkamp, Sophie Papa, Viola Franke, Andreas Pinter

Adv Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response to talimogene laherparepvec in a primary acral lentiginous melanoma.
Viola Franke, Philippe M G Smeets, Jacqueline E van der Wal, Alexander C J van Akkooi

Melanoma Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in sentinel node pathology in the era of adjuvant treatment.
Viola Franke, Max F Madu, Carolien Bierman, Willem M C Klop, Winan J van Houdt

J Surg Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Max F Madu, Viola Franke, Bart A Van de Wiel, Willem M C Klop, Katarzyna Jóźwiak

Melanoma Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High response rates for T-VEC in early metastatic melanoma (stage IIIB/C-IVM1a).
Viola Franke, Danique M S Berger, W Martin C Klop, Bernies van der Hiel, Bart A van de Wiel

Int J Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The extent of surgery for stage III melanoma: how much is appropriate?
Viola Franke, Alexander C J van Akkooi

Lancet Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
Eduardo Bertolli, Viola Franke, Vinicius Fernando Calsavara, Mariana Petaccia de Macedo, Clovis Antonio Lopes Pinto

Ann Surg Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma.
Viola Franke, Bernies van der Hiel, Bart A van de Wiel, Willem M C Klop, Sylvia Ter Meulen

Eur J Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.
Max F Madu, Viola Franke, Maarten M Bruin, Danique M S Berger, Carolien Bierman

Eur J Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exogenous Cushing's syndrome due to a Chinese herbalist's prescription of ointment containing dexamethasone.
Viola Franke, Winnie Francien Scholtens, Ines Alexandra von Rosenstiel, Marie Jose Walenkamp

BMJ Case Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis